退伍军人医院非ST段抬高型急性冠脉综合征早期双联抗血小板治疗现状与结局
早期DAPT存在超过两倍的院间差异,与死亡或心梗风险降低无关,却与外科血运重建延迟相关。
要点
- NSTEACS造影患者中仅33%接受早期DAPT,院间差异超过两倍。
- 早期DAPT未降低死亡或心梗风险(HR 1.08,95%CI 1.00-1.16)。
- 早期DAPT与外科血运重建延迟相关(中位4天 vs 3天,p<0.001)。
核心结论
- 在接受冠脉造影的NSTEACS患者中,早期DAPT与结局改善无关,却与外科血运重建延迟相关。
主要发现
- 早期DAPT院间差异超过两倍,独立于患者特征(中位OR 2.43,95%CI 2.28-2.55)。
- 两组PCI时间无差异,但早期DAPT组外科血运重建延迟(中位4天 vs 3天,p<0.001)。
- 早期DAPT未降低死亡或心梗风险(HR 1.08,95%CI 1.00-1.16),血运重建亚组结果相似(HR 1.02,95%CI 0.91-1.13)。
临床怎么用
- NSTEACS造影患者早期DAPT使用率低且院间差异大,需关注实践一致性。
- 对可能需要外科血运重建的患者,早期DAPT应权衡出血与手术延迟风险。
局限性
- 为观察性分析,可能存在未测量混杂。
- 仅纳入退伍军人医院人群,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current guidelines recommend that patients with non-ST elevation acute coronary syndromes (NSTEACS) receive dual antiplatelet therapy (DAPT) early in hospitalisations. However, observational studies suggest that this rarely occurs. We evaluated site-specific variation and clinical outcomes associated with early DAPT among patients undergoing angiography for NSTEACS. METHODS: In this observational analysis, we identified patients undergoing angiography for NSTEACS in Veterans Affairs hospitals from 2008 to 2016 and assessed characteristics and site variation associated with early DAPT (administration <24 hours of admission). Using propensity matching, we compared time to revascularisation, recurrent myocardial infarction (MI) and mortality between those receiving early DAPT and those not receiving early DAPT (administration ≥24 hours). RESULTS: Of 45 569 patients undergoing angiography for NSTEACS, 15 084 (33%) received early DAPT. Early DAPT was more frequent in patients with non-ST elevation MI, prior surgical revascularisation and among patients undergoing revascularisation. There was a greater than twofold difference in early DAPT across sites, independent of patient characteristics (median OR 2.43, 95% CI 2.28 to 2.55). There was no difference in time topercutaneous coronary intervention (PCI) between groups, but a significant delay to surgical revascularisation with early DAPT (median 4 vs 3 days, p<0.001) without reduction in hazard of death or MI (HR 1.08, 95% CI 1.00 to 1.16) and similar results demonstrated in the subgroup of patients undergoing revascularisation (HR 1.02, 95% CI 0.91 to 1.13). CONCLUSION: Among NSTEACS patients undergoing coronary angiography, early DAPT was not associated with improvement of outcomes but was associated with delays in surgical revascularisation.
引用
- Valle JA, Josey K, Prouse AF, et al. Dual antiplatelet therapy in non-ST elevation acute coronary syndromes at Veterans Affairs Hospitals. Heart. 2019. PMID: 31092547. doi:10.1136/heartjnl-2018-314553
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。